Показано 0 из 0
Дата |
---|
23:00 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.38
|
0.389
|
0.4077
|
0.383899
|
0.424
|
0.383899
|
|
|
5 664.56
|
31.00
|
0.40
|
0.435
|
0.422
|
0.4051
|
0.43
|
0.408
|
|
|
11 384.26
|
83.00
|
0.4269
|
0.4318
|
0.4497
|
0.3995
|
0.4517
|
0.4446
|
|
|
31 736.59
|
136.00
|
0.4057
|
0.4399
|
0.379
|
0.3627
|
0.4951
|
0.479
|
|
|
54 041.88
|
230.00
|
0.37
|
0.3999
|
0.3428
|
0.34
|
0.40
|
0.3798
|
|
|
33 566.55
|
122.00
|
0.32
|
0.3535
|
0.336
|
0.33
|
0.35
|
0.35
|
|
|
7 944.38
|
34.00
|
0.3134
|
0.34
|
0.32
|
0.31
|
0.34
|
0.336
|
|
|
2 323.77
|
23.00
|
0.3003
|
0.36
|
0.345
|
0.316
|
0.35
|
0.3399
|
|
|
4 935.47
|
33.00
|
0.3121
|
0.34
|
0.318
|
0.318
|
0.3465
|
0.3465
|
|
|
10 737.68
|
71.00
|
0.291
|
0.3134
|
0.3019
|
0.2926
|
0.33
|
0.2951
|
|
|
9 953.08
|
132.00
|
BiomX Inc. operates as a microbiome company. The Company focuses on developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and colorectalcancer (CRC), as well as bacteria that affect the appearance of the skin. BiomX serves customers worldwide.